|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS10163|
Digital Pathology Market Overview
The global digital pathology market size is expected to register significant growth in the coming years, particularly due to the rising prevalence of chronic diseases, growing adoption of digital pathology products for improving the efficiency of laboratories around the world, and increasing government initiatives and collaboration with market players for raising awareness regarding the innovative digital pathology technologies and products.
The different products offered by digital pathology are storage systems, scanners, communication systems, and software. Among these, the largest digital pathology market share is predicted to be held by the software category in the near future due to the availability of reliable and user-friendly software which enables the highest level of accuracy within the digital devices. In addition, the surging patient pool will result in rising requirement for this software, further driving the growth of the market.
Veterinary pathology and human pathology are the two types of digital pathology. Between these two, the human pathology type is projected to account for the larger share of the digital pathology market in the coming years, owing to the increasing burden of chronic diseases, such as hepatitis A, cancer, and hepatitis B. Critical monitoring is required during the treatment of these diseases, which is possible because of the accurate consultations provided by digital pathology services.
The various applications of digital pathology are drug discovery, teleconsultation, training & education, and diseases diagnosis. Out of these, the teleconsultation application is expected to account for a significant share of the digital pathology market, as digital pathology is being widely utilized for consulting the geriatric population. Moreover, since the geriatric population is more susceptible to different chronic diseases, the requirement for teleconsultation will increase with the rise in aging population. The disease diagnosis application is projected to grow at a considerable rate in the coming years because of the rising prevalence of viral and bacterial diseases.
Among the different end users of digital pathology, namely academic institutes & research laboratories, hospitals & clinics, and pharmaceutical & biotechnology companies, the pharmaceutical and biotechnology companies are predicted to hold the largest share of the digital pathology market in the coming years. The reason for this is that these companies make use of digital pathology for several activities, such as molecular assays, biopharmaceutical studies, and biobanking.
North America is predicted to contribute the largest revenue share to the digital pathology market in the near future because of the increasing healthcare expenditure, growing adoption of digital pathology in the region, supportive government initiatives regarding the development of technologically advanced systems. The fastest growth is expected to be registered by the Asia-Pacific region in the coming years, attributing to the swift economic growth, rising focus of governments on spreading the awareness regarding digital pathology, and expanding pharmaceutical & biotechnology industry.
Digital Pathology Market Dynamics
The rising prevalence of different chronic diseases is among the key driving factors of the digital pathology market growth. The burden of cancer, specifically, is growing rapidly. As per the World Health Organization (WHO), the second-leading cause of death around the world is cancer, which was responsible for 8.8 million deaths in 2015. Over the next two years, the number of new cancer cases is predicted to rise to about 70%. Attributed to this, the demand for faster and more efficient and accurate methods of diagnosing diseases is increasing rapidly. Diagnostic pathology systems provide easy exchange of data among pathologists and accurate diagnosis, thereby enhancing diagnostic quality.
In addition to this, the digital pathology market is expected to grow significantly in the coming years, owing to the rising adoption of this technology in emerging economies. As per WHO, just about 26% of the low-income countries were reported to have pathology services available in the public sector in 2017. However, the governments of such countries are increasingly focusing on spreading awareness regarding digital pathology, which will lead to the growth of the industry.
Due to technological advancements, efforts towards the integration of laboratory information system (LIS) with digital pathology system are being made, which, in turn, is predicted to create wide opportunities for the players operating in the digital pathology market. The market players will be able to increase their revenue by offering implementation and installation of services which integrate both LIS and digital pathology system. Several laboratories are trying to integrate these systems, which is expected to aid in streamlining digital sign-out workflow, reducing delivery cost of glass slides, and minimizing unnecessary and error-prone manual work.
Digital Pathology Market Competitive Landscape
The digital pathology market players are developing and introducing new digital pathology solutions. For example, F. Hoffmann-La Roche AG launched VENTANA DP 200, which is a high-speed slide scanner for digital pathology, in 2018. This scanner is able to produce high-quality images due to its tray-based design.
Some other key players in the global digital pathology market are Koninklijke Philips N.V., Danaher Corporation, Hamamatsu Photonics, Apollo Enterprise Imaging Corporation, 3DHISTECH Ltd, XIFIN Inc., Huron Digital Pathology, Visiopharm A/S, Indica Labs, and Corista.
By End User